Rise in defibrillation threshold after postoperative cardiac remodeling in a patient with severe Ebstein’s anomaly

Rise in defibrillation threshold after postoperative cardiac remodeling in a patient with severe Ebstein’s anomaly

Bibliographic Details
Main Authors:	Reina Bianca Tan, MD, Charles Love, MD, FHRS, Dan Halpern, MD, Frank Cecchin, MD
Format:	Article
Language:	English
Published:	Elsevier 2017-06-01
Series:	HeartRhythm Case Reports
Subjects:	Arrhythmia Ventricular fibrillation Implantable cardioverter-defibrillator Computerized tomography (CT) Magnetic resonance imaging (MRI)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027117300477

Similar Items

Electroanatomical mapping of the atrialized right ventricle: Placement of a transvenous implantable cardioverter-defibrillator in a patient with Ebstein’s anomaly
by: Masahiro Wanezaki, MD, et al.
Published: (2014-10-01)

A Recalcitrant Electrical Storm and Implantable Defibrillator Exhaustion
by: Christos Kontogiannis, MD, et al.
Published: (2019-12-01)

Coronary vein defibrillator coil placement in patients with high defibrillation thresholds
by: Moisés Rodríguez‐Mañero, et al.
Published: (2019-02-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management
by: Malik Shehadeh, MD, et al.
Published: (2020-12-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
by: Matthew F. Yuyun, MD, MPhil, PhD, et al.
Published: (2020-05-01)

Decline in physical activity in the weeks preceding sustained ventricular arrhythmia in women
by: Ashley E. Burch, PhD, et al.
Published: (2020-10-01)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
by: Maciej Kempa, et al.
Published: (2021-07-01)

Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report
by: Takashi Kanda, MD, et al.
Published: (2015-06-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
by: Florian Blaschke, et al.
Published: (2021-08-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

High Defibrillation Threshold: The Science, Signs and Solutions
by: Sony Jacob, et al.
Published: (2010-01-01)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
by: Amit Noheria, MBBS, SM, et al.
Published: (2014-11-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker
by: Paul S.G. Hong, MRCP, et al.
Published: (2015-01-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Unheralded failure of Riata defibrillator lead identified at defibrillation threshold testing
by: Matthew R. Webber, MB ChB, FRACP, et al.
Published: (2013-06-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application
by: Mark E. Panna Jr, MD, FACC, FHRS, et al.
Published: (2016-02-01)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
by: Naga VA Kommuri, et al.
Published: (2010-01-01)

Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

Low-energy cardioversion of ventricular tachycardia: When less is more
by: Haran Burri, MD, et al.
Published: (2017-03-01)

A broken lead to an open heart: implantable cardioverter defibrillator vegetations with lead fracture
by: George Horani, MD, et al.
Published: (2021-11-01)

Systemic infection due to subcutaneous implantable cardioverter-defibrillator implantation: Importance of early recognition and treatment of device pocket-related complications
by: Patrick M. Looser, MD, et al.
Published: (2017-01-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
by: Hirotaro Sugiyama, MD, et al.
Published: (2017-06-01)

Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment?
by: Jeremy W. Docekal, MD, et al.
Published: (2016-09-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01)

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry
by: Berardo Sarubbi, et al.
Published: (2021-05-01)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
by: Daisuke Ishigaki, M.D., et al.
Published: (2016-12-01)

Left-Sided Humerus Fracture as an Unusual Complication of Defibrillation Threshold Testing Following S-ICD Implantation
by: Jan Elders, MA, et al.
Published: (2020-02-01)